MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,178,000 | -59.3% | 34,298 | -57.1% | 0.02% | -65.4% |
| Q3 2017 | $2,891,000 | +123.2% | 79,904 | +59.3% | 0.05% | +85.7% |
| Q2 2017 | $1,295,000 | -14.5% | 50,151 | -36.4% | 0.03% | -15.2% |
| Q1 2017 | $1,515,000 | +41.9% | 78,911 | +23.1% | 0.03% | 0.0% |
| Q4 2016 | $1,068,000 | +51.7% | 64,093 | +87.4% | 0.03% | +26.9% |
| Q3 2016 | $704,000 | +45.2% | 34,205 | +116.0% | 0.03% | 0.0% |
| Q2 2016 | $485,000 | +61.1% | 15,839 | +97.0% | 0.03% | +36.8% |
| Q1 2016 | $301,000 | -88.5% | 8,041 | -86.7% | 0.02% | -90.6% |
| Q4 2015 | $2,615,000 | +567.1% | 60,582 | +478.9% | 0.20% | +225.8% |
| Q3 2015 | $392,000 | -92.4% | 10,465 | -93.1% | 0.06% | -69.8% |
| Q2 2015 | $5,152,000 | -4.8% | 151,562 | -0.9% | 0.20% | -5.1% |
| Q1 2015 | $5,414,000 | +122.8% | 152,946 | +114.4% | 0.22% | +72.8% |
| Q4 2014 | $2,430,000 | +494.1% | 71,353 | +572.4% | 0.12% | +290.6% |
| Q3 2014 | $409,000 | – | 10,611 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |